Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
- PMID: 26485620
- DOI: 10.1164/rccm.201505-1040OC
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
Abstract
Rationale: As of April 2015, participants in the Danish Lung Cancer Screening Trial had been followed for at least 5 years since their last screening.
Objectives: Mortality, causes of death, and lung cancer findings are reported to explore the effect of computed tomography (CT) screening.
Methods: A total of 4,104 participants aged 50-70 years at the time of inclusion and with a minimum 20 pack-years of smoking were randomized to have five annual low-dose CT scans (study group) or no screening (control group).
Measurements and main results: Follow-up information regarding date and cause of death, lung cancer diagnosis, cancer stage, and histology was obtained from national registries. No differences between the two groups in lung cancer mortality (hazard ratio, 1.03; 95% confidence interval, 0.66-1.6; P = 0.888) or all-cause mortality (hazard ratio, 1.02; 95% confidence interval, 0.82-1.27; P = 0.867) were observed. More cancers were found in the screening group than in the no-screening group (100 vs. 53, respectively; P < 0.001), particularly adenocarcinomas (58 vs. 18, respectively; P < 0.001). More early-stage cancers (stages I and II, 54 vs. 10, respectively; P < 0.001) and stage IIIa cancers (15 vs. 3, respectively; P = 0.009) were found in the screening group than in the control group. Stage IV cancers were nonsignificantly more frequent in the control group than in the screening group (32 vs. 23, respectively; P = 0.278). For the highest-stage cancers (T4N3M1, 21 vs. 8, respectively; P = 0.025), this difference was statistically significant, indicating an absolute stage shift. Older participants, those with chronic obstructive pulmonary disease, and those with more than 35 pack-years of smoking had a significantly increased risk of death due to lung cancer, with nonsignificantly fewer deaths in the screening group.
Conclusions: No statistically significant effects of CT screening on lung cancer mortality were found, but the results of post hoc high-risk subgroup analyses showed nonsignificant trends that seem to be in good agreement with the results of the National Lung Screening Trial. Clinical trial registered with www.clinicaltrials.gov (NCT00496977).
Keywords: chronic obstructive pulmonary disease; computed tomography; lung cancer; screening.
Comment in
-
Screening for Lung Cancer. Improving Outcomes with Better Patient Selection.Am J Respir Crit Care Med. 2016 Mar 1;193(5):478-9. doi: 10.1164/rccm.201510-2096ED. Am J Respir Crit Care Med. 2016. PMID: 26930429 No abstract available.
-
Personalized lung cancer screening: the value of spirometry and emphysema as risk modifiers.Ann Transl Med. 2016 Aug;4(15):293. doi: 10.21037/atm.2016.05.59. Ann Transl Med. 2016. PMID: 27569222 Free PMC article. No abstract available.
Similar articles
-
Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis.PLoS One. 2016 Oct 13;11(10):e0164416. doi: 10.1371/journal.pone.0164416. eCollection 2016. PLoS One. 2016. PMID: 27736916 Free PMC article. Review.
-
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6. Lancet Oncol. 2016. PMID: 27283862 Clinical Trial.
-
Lung cancer histologies associated with emphysema on computed tomography.Lung Cancer. 2012 Apr;76(1):61-6. doi: 10.1016/j.lungcan.2011.09.003. Epub 2011 Sep 25. Lung Cancer. 2012. PMID: 21945657
-
The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.J Thorac Oncol. 2009 May;4(5):608-14. doi: 10.1097/JTO.0b013e3181a0d98f. J Thorac Oncol. 2009. PMID: 19357536 Clinical Trial.
-
CT screening for lung cancer: past and ongoing studies.Semin Thorac Cardiovasc Surg. 2005 Summer;17(2):99-106. doi: 10.1053/j.semtcvs.2005.05.002. Semin Thorac Cardiovasc Surg. 2005. PMID: 16087075 Review.
Cited by
-
[Lung cancer screening: new frontiers].Radiologie (Heidelb). 2024 Jun;64(6):456-462. doi: 10.1007/s00117-024-01322-z. Epub 2024 May 21. Radiologie (Heidelb). 2024. PMID: 38772915 German.
-
Lung cancer screening in Brazil: recommendations from the Brazilian Society of Thoracic Surgery, Brazilian Thoracic Association, and Brazilian College of Radiology and Diagnostic Imaging.J Bras Pneumol. 2024 Mar 22;50(1):e20230233. doi: 10.36416/1806-3756/e20230233. eCollection 2024. J Bras Pneumol. 2024. PMID: 38536982 Free PMC article. Review.
-
Enhancing a deep learning model for pulmonary nodule malignancy risk estimation in chest CT with uncertainty estimation.Eur Radiol. 2024 Mar 27. doi: 10.1007/s00330-024-10714-7. Online ahead of print. Eur Radiol. 2024. PMID: 38536463
-
The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions.BMC Cancer. 2024 Mar 5;24(1):299. doi: 10.1186/s12885-024-12052-9. BMC Cancer. 2024. PMID: 38443800 Free PMC article.
-
[Effectiveness Evaluation of Low-dose Spiral Computed Tomography for Lung Cancer Screening in Minhang District of Shanghai].Zhongguo Fei Ai Za Zhi. 2024 Jan 20;27(1):13-24. doi: 10.3779/j.issn.1009-3419.2023.102.46. Zhongguo Fei Ai Za Zhi. 2024. PMID: 38296622 Free PMC article. Chinese.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous